Allosteric Modulation of Protease-Activated Receptor Signaling

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|12|9|804-811

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.12, Iss.9, 2012-08, pp. : 804-811

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Multiple Layers of Signaling Selectivity at Protease-Activated Receptors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 2, 2012-01 ,pp. : 161-174

Bentham Science Publishers

Access to resources Recommend Favorite

Vorapaxar: a novel protease-activated receptor-1 inhibitor

By Gurbel Paul A   Jeong Young-Hoon   Tantry Udaya S  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1445-1453

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes

By Debeir T.   Vige X.   Benavides J.  

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Protease-activated receptor 2 signalling pathways: a role in pain processing

By Bao Yanju   Hou Wei   Hua Baojin  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 15-27

Informa Healthcare

Access to resources Recommend Favorite